Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022

SELL
$5.16 - $7.14 $20,640 - $28,560
-4,000 Reduced 4.81%
79,241 $492,000
Q3 2021

Nov 12, 2021

SELL
$6.98 - $8.47 $46,396 - $56,300
-6,647 Reduced 7.39%
83,241 $581,000
Q1 2021

May 14, 2021

SELL
$3.91 - $6.99 $89,812 - $160,560
-22,970 Reduced 20.35%
89,888 $491,000
Q3 2020

Nov 12, 2020

SELL
$2.75 - $4.2 $6,558 - $10,017
-2,385 Reduced 2.07%
112,858 $340,000
Q1 2019

Apr 30, 2019

SELL
$2.77 - $4.38 $8,310 - $13,140
-3,000 Reduced 2.54%
115,243 $497,000
Q4 2018

Feb 12, 2019

SELL
$3.03 - $5.0 $144,491 - $238,435
-47,687 Reduced 28.74%
118,243 $376,000
Q3 2018

Nov 13, 2018

BUY
$5.0 - $6.65 $15,000 - $19,950
3,000 Added 1.84%
165,930 $871,000
Q2 2018

Aug 14, 2018

BUY
$4.2 - $5.95 $684,306 - $969,433
162,930 New
162,930 $872,000

Others Institutions Holding HBIO

About HARVARD BIOSCIENCE INC


  • Ticker HBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 41,636,500
  • Market Cap $89.1M
  • Description
  • Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...
More about HBIO
Track This Portfolio

Track First Republic Investment Management, Inc. Portfolio

Follow First Republic Investment Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Republic Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First Republic Investment Management, Inc. with notifications on news.